Fulcrum Therapeutics Inc (FULC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 1,882 | 2,592 | 5,058 | 4,935 | 4,381 |
| Gross Profit | 1,882 | 2,592 | 5,058 | 4,935 | 4,381 |
| Operating Expenses | 36,117 | 28,590 | 28,617 | 25,705 | 24,063 |
| Operating Income | -34,235 | -25,998 | -23,559 | -20,770 | -19,682 |
| Other Income | 165 | 70 | 75 | 54 | 34 |
| Pre-tax Income | -34,070 | -25,928 | -23,484 | -20,716 | -19,648 |
| Net Income Continuous | -34,070 | -25,928 | -23,484 | -20,716 | -19,648 |
| Net Income | $-34,070 | $-25,928 | $-23,484 | $-20,716 | $-19,648 |
| EPS Basic Total Ops | -0.83 | -0.64 | -0.58 | -0.57 | -0.60 |
| EPS Basic Continuous Ops | -0.83 | -0.64 | -0.58 | -0.57 | -0.60 |
| EPS Diluted Total Ops | -0.83 | -0.64 | -0.58 | -0.57 | -0.60 |
| EPS Diluted Continuous Ops | -0.83 | -0.64 | -0.58 | -0.57 | -0.60 |
| EBITDA(a) | $-33,559 | $-25,462 | $-22,938 | $-20,151 | $-19,010 |